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Lysosomes provide a major source for cellular cholesterol; however, most of this cholesterol is
trafficked to the plasma membrane via unknown mechanisms. Chu et al. identify an unexpected
role for peroxisomes in the transport of cholesterol from the lysosome to the plasma membrane
via a lysosome-peroxisome membrane contact site.Cholesterol is an essential determinant
of membrane fluidity, permeability, and
organization in animal cells. While the
vast majority of cellular cholesterol (about
60%–80%) is localized at the plasma
membrane (PM) (Maxfield and Wu¨stner,
2002), cholesterol originates from the ER
via biosynthesis and the lysosome via
import of exogenous cholesterol. These
observations raise a fundamental ques-
tion, how is cholesterol transported from
the ER or lysosome to the PM? In this
issue of Cell, Chu et al. (2015) discover
that peroxisomes play a critical role in
the transport of cholesterol from the lyso-
some to the PM and uncover an unex-
pected membrane contact site between
the peroxisome and lysosome (Figure 1).
Exogenous cholesterol enters the cell
as low density lipoproteins (LDL) via
endocytosis of the LDL receptor. Upon
delivery to the lysosome, LDL-derived
cholesterol esters are de-esterified into
free cholesterol then exported to other
compartments including the PM (Maxfield
and Wu¨stner, 2002). The physiological
importance of cholesterol transport out
of the lysosome is underscored by Nie-
mann-Pick disease type C (NPC). NPC is
a fatal, predominantly neurodegenerative
disorder caused by mutations in NPC1
or NPC2, which results in cholesterol
accumulation in the lysosome. NPC1
and NPC2 work together to transport
free cholesterol out of the lumen to the
limiting membrane of the lysosome (Du
et al., 2011; Kwon et al., 2009; Vanier,
2015). Themolecular mechanisms of sub-
sequent steps, exit of cholesterol from the
lysosomal membrane and delivery to the
PM, were largely uncharacterized.
To identify proteins required for trans-
port of LDL-derived cholesterol, Chuet al. (2015) design an elegant screen
that takes advantage of the antibiotic
Amphotericin C, which permeablilizes
the PM through association with exposed
cholesterol, as well as U18666A, which
enables them to stage the release of
LDL-derived cholesterol from the lyso-
some. Using shRNA, they identify 341
candidate genes. Surprisingly, several
candidates are related to peroxisomal
function and biogenesis. Knockdown of
these peroxisome related genes results
in the accumulation of cholesterol in the
lysosome lumen.
Analysis of cultured wild-type cells
by both fluorescence microscopy and
transmission electron microscopy reveals
a previously unrecognized membrane
contact site between lysosomes and
peroxisomes. Further evidence for the
lysosome-peroxisome contact site is
provided by multiple in vitro studies
demonstrating an interaction between
these organelles. Chu et al. find that the
lysosome-peroxisome contact site is
bridged, at least in part, by the integral
lysosomal membrane protein, synapto-
tagmin 7 (syt7), through binding to
PI(4,5)P2 on the peroxisomal membrane.
The lysosome-peroxisome contact site
is transient and cholesterol-dependent.
Notably, efficient formation of the lyso-
some-peroxisome contact site also re-
quires NPC1 suggesting that this contact
is important for cholesterol exit from the
lysosome.
Three of the peroxisomal genes identi-
fied in this study have been implicated in
human diseases. X-linked adrenoleuko-
dystrophy, Infantile Refsum disease, and
Zellweger syndrome are caused by muta-
tions in ABCD1, PEX1, and PEX26 (Au-
bourg and Wanders, 2013). Strikingly,CelChu et al. (2015) show that cells from
patients suffering from each of these dis-
eases accumulate cholesterol in lyso-
somes to a similar extent as those from
NPC patients. The potential contribution
of defects in cholesterol trafficking to
symptoms of these diseases must now
be considered.
The precise roles of the lysosome-
peroxisome contact site in facilitating
cholesterol transport out of the lysosome
on its path to the PM remains to be deter-
mined. Chu et al. (2015) provide evidence
from in vitro, as well as cell-based studies,
that cholesterol is transferred from lyso-
somes to peroxisomes via the lysosome-
peroxisome membrane contact site,
raising the possibility that cholesterol
may transit through the peroxisome on
its way to the PM. It is also possible
that the contact site facilitates transport
of cholesterol out of the lysosome
directly to a different organelle, such as
the ER. In support of this possibility,
knockdown of the oxysterol binding
protein-related protein 5 (ORP5), which
is localized to the ER, has been shown
to result in accumulation of NPC1 depen-
dent pools of cholesterol in the limiting
membrane of the lysosome (Du et al.,
2011). Orp5 may act in a parallel pathway,
or downstream of Syt7 and ABCD1 in
the transfer of cholesterol out of the
lysosome, either to the ER or to the perox-
isome.
Different pathways of cholesterol trans-
port out of the lysosome may function in
different cell types or under different con-
ditions and perhaps only a subset of these
pathways are directed to the PM. A
comprehensive assessment of themolec-
ular components of the lysosome-peroxi-
some contact, including the considerationl 161, April 9, 2015 ª2015 Elsevier Inc. 197
Figure 1. The Lysosome-Peroxisome Contact Site Joins a Growing List of Inter-Organelle
Contact Sites
Known contact sites between the ER-mitochondria, ER-PM, ER-vacuole, ER-endosome/lysosome, ER-
peroxisome, ER-Golgi, ER-phagosome, ER-lipid droplet, mitochondria-PM, and mitochondria-lysosome/
vacuole are indicated.of a possible three-way lysosome-peroxi-
some-ER junction, is necessary. This
knowledge will be critical to understand-
ing the peroxisome-dependent mecha-
nisms of cholesterol transport out of the
lysosome and for the development of
disease therapies.
The lysosome-peroxisome contact site
joins a growing list of inter-organelle con-
tact sites. The known membrane contact
sites currently include: ER-mitochondria,
ER-PM, ER-lysosome/vacuole, ER-endo-
some, ER-Golgi, mitochondria-lysosome/
vacuole, and mitochondria-PM (Prinz,
2014). Note that the lysosome-peroxi-
some contact site is now the third
example of a critical contact between
the lysosome and another organelle.
Among the identified contact sites, some
share partial functional redundancy. For
example, the ER-mitochondrial encounter198 Cell 161, April 9, 2015 ª2015 Elsevier Incstructure (ERMES) and the vacuole and
mitochondria patch (vCLAMP) are distinct
membrane contact sites that connect the
mitochondria to the ER and the yeast
vacuole, respectively (Elbaz-Alon et al.,
2014; Ho¨nscher et al., 2014). Loss
of either the ERMES or the vCLAMP
has minimal phenotypic consequences,
whereas simultaneous loss of both is
lethal. Additional inter-organelle contacts
are likely to be discovered.
In addition to specialized functions
including calcium homeostasis and stor-
age, intracellular signaling, organelle divi-
sion, and lipid biosynthesis, membrane
contact sites have repeatedly been
shown to facilitate lipid transfer between
membranes (Elbaz and Schuldiner, 2011;
Prinz, 2014). It is tempting to speculate
that inter-organelle contacts are the
major routes of lipid transfer between.cellular compartments and fundamental
to the accurate distribution of distinct
lipid species throughout the cell.
Currently, we are limited in our ability
to observe the movements of lipids
within cells because robust assays for
tracking most lipids via microscopy do
not yet exist. The development of
methods facilitating such observations
will be invaluable to advancement of
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